The bottom line of CAR-T fungal risk: low incidence, high stakes and the need for individualised antifungal prophylaxis
Details
Publication Year 2025-01,Volume 31,Issue #1,Page 4-6
Journal Title
Transplantation and Cellular Therapy
Publication Type
Commentary
Publisher
Elsevier
Department(s)
Infectious Diseases
Open Access at Publisher's Site
https://doi.org/10.1016/j.jtct.2024.12.013
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-01-13 05:40:51
Last Modified: 2026-01-13 05:41:14
An error has occurred. This application may no longer respond until reloaded. Reload 🗙